Pharmaceutical Surface Science Research Group, School of Pharmacy and Pharmacology, University of Bath, Bath, UK.
Int J Pharm. 2010 May 10;390(2):134-41. doi: 10.1016/j.ijpharm.2010.01.028. Epub 2010 Jan 25.
The relationships between the physicochemical properties and functionality in dry powder inhaler (DPI) performance was investigated for inhalation grade anhydrous lactose and compared to monohydrate grades. The excipients were characterised using a range of techniques including particle size analysis, moisture sorption and powder rheometry. The inhalation anhydrous lactose grades were readily characterisable. The aerosolisation performance of capsule based DPI formulations containing budesonide (200microg) and different grades of lactose evaluated using inertial impaction measurements produced fine particle doses of budesonide ranging from 24 to 49microg. There were no apparent relationships between aerosolisation performance and excipient characteristics, such as particle size and powder density. However, formulations containing lactose grades which exhibit higher powder fluidisation energy values resulted in higher fine particle doses of budesonide.
研究了干粉吸入器(DPI)性能中物理化学性质与功能之间的关系,考察了吸入级无水乳糖,并与一水乳糖进行了比较。使用一系列技术对辅料进行了表征,包括粒度分析、水分吸附和粉末流变性。可轻易对吸入无水乳糖进行特性描述。使用惯性撞击测量评估含有布地奈德(200μg)和不同乳糖的胶囊型 DPI 制剂的气溶胶化性能,产生的布地奈德细颗粒剂量范围为 24 至 49μg。气溶胶化性能与辅料特性(如粒径和粉末密度)之间似乎没有明显的关系。然而,含有表现出更高粉末流化能量值的乳糖级别的制剂导致布地奈德的细颗粒剂量更高。